Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FNBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MORC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DLAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAFK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LARS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC400927-CSNK1E - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PATZ1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL4R - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRKD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TUG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
RAC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF667-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HTT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL6IP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANAPC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MARCH6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VMA21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HMGB3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2QL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on